aTyr Pharma reported $-153K in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Ardelyx USD -37.6M 37.2M Mar/2026
aTyr Pharma USD -153K 24.71M Mar/2026
Biogen USD 319.5M 368.4M Mar/2026
Bristol-Myers Squibb USD 2.68B 1.59B Mar/2026
Cipla INR 5.55B 1.21B Mar/2026
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD -7.67M 64.51M Mar/2026
CSL USD 401M 96.5M Dec/2025
Curis USD 19.36M 31.16M Dec/2025
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
Grifols EUR 114.37M 34.03M Dec/2025
Lakefront Biotherapeutics EUR 14.49M 767.65M Mar/2026
Novartis USD 3.16B 747M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
United Therapeutics USD 274.9M 89.4M Mar/2026